Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells

Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells

Abstract Background Hormonal receptor positive (HR+) breast cancer is the most commonly diagnosed molecular subtype of breast cancer; which showed good response to doxorubicin (DOX)-based chemotherapy. Eugenol (EUG) and astaxanthin (AST) are natural compounds with proved epigenetic and immunomodulat...

Full description

Bibliographic Details
Main Authors: Mariam A. Fouad, Mohamed M. Sayed-Ahmed, Etimad A. Huwait, Hafez F. Hafez, Abdel-Moneim M. Osman
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Pharmacology and Toxicology
Subjects:
Eugenol
Astaxanthin
Doxorubicin
Breast Cancer cells
Online Access:https://doi.org/10.1186/s40360-021-00473-2

Similar Items

Similar Items